Advertisement

Topics

Rucaparib boosts progression-free survival in BRCA mutant recurrent ovarian cancer

20:00 EDT 7 Sep 2017 | AAAS

(European Society for Medical Oncology) Rucaparib maintenance therapy increases progression-free survival in BRCA mutant recurrent ovarian cancer by 77%, according to late-breaking results from the ARIEL3 trial reported today at the ESMO 2017 Congress in Madrid.

Original Article: Rucaparib boosts progression-free survival in BRCA mutant recurrent ovarian cancer

NEXT ARTICLE

More From BioPortfolio on "Rucaparib boosts progression-free survival in BRCA mutant recurrent ovarian cancer"

Quick Search
Advertisement
 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...